News Releases Year None2023202220212020201920182017 NuCana plc Announces Pricing of Initial Public Offering Sep 27, 2017 NuCana Announces Interim Data from First-In-Human Study of Transformative Anti-Cancer Agent, NUC-3373 Sep 13, 2017 NuCana Announces Positive Results of NUC-1031 (Acelarin®) in Advanced Ovarian Cancer at ESMO 2017 (6151) Sep 12, 2017 Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12
NuCana Announces Interim Data from First-In-Human Study of Transformative Anti-Cancer Agent, NUC-3373 Sep 13, 2017
NuCana Announces Positive Results of NUC-1031 (Acelarin®) in Advanced Ovarian Cancer at ESMO 2017 (6151) Sep 12, 2017